NovoBiotic Pharmaceuticals, LLC announces the discovery and preclinical development of teixobactin, a compound belonging to a new class of antibiotics.
As reported in the journal Nature (Ling et. al....
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.